Hospitalization frequency and charges for neurocysticercosis, United States, 2003–2012

Seth O'Neal, Robert H. Flecker

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Neurocysticercosis, brain infection with Taenia solium larval cysts, causes substantial neurologic illness around the world. To assess the effect of neurocysticercosis in the United States, we reviewed hospitalization discharge data in the Nationwide Inpatient Sample for 2003–2012 and found an estimated 18,584 hospitalizations for neurocysticercosis and associated hospital charges totaling >US $908 million. The risk for hospitalization was highest among Hispanics (2.5/100,000 population), a rate 35 times higher than that for the non-Hispanic white population. Nearly three-quarters of all hospitalized patients with neurocysticercosis were Hispanic. Male sex and age 20–44 years also incurred increased risk. In addition, hospitalizations and associated charges related to cysticercosis far exceeded those for malaria and were greater than for those for all other neglected tropical diseases combined. Neurocysticercosis is an increasing public health concern in the United States, especially among Hispanics, and costs the US health care system a substantial amount of money.

Original languageEnglish (US)
Pages (from-to)969-976
Number of pages8
JournalEmerging Infectious Diseases
Volume21
Issue number6
DOIs
StatePublished - 2015

Fingerprint

Neurocysticercosis
Hospitalization
Hispanic Americans
Taenia solium
Neglected Diseases
Hospital Charges
Cysticercosis
Nervous System
Population
Malaria
Cysts
Inpatients
Public Health
Delivery of Health Care
Costs and Cost Analysis
Brain
Infection

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases
  • Epidemiology

Cite this

Hospitalization frequency and charges for neurocysticercosis, United States, 2003–2012. / O'Neal, Seth; Flecker, Robert H.

In: Emerging Infectious Diseases, Vol. 21, No. 6, 2015, p. 969-976.

Research output: Contribution to journalArticle

@article{66b20a533e554632820c3dcd09124314,
title = "Hospitalization frequency and charges for neurocysticercosis, United States, 2003–2012",
abstract = "Neurocysticercosis, brain infection with Taenia solium larval cysts, causes substantial neurologic illness around the world. To assess the effect of neurocysticercosis in the United States, we reviewed hospitalization discharge data in the Nationwide Inpatient Sample for 2003–2012 and found an estimated 18,584 hospitalizations for neurocysticercosis and associated hospital charges totaling >US $908 million. The risk for hospitalization was highest among Hispanics (2.5/100,000 population), a rate 35 times higher than that for the non-Hispanic white population. Nearly three-quarters of all hospitalized patients with neurocysticercosis were Hispanic. Male sex and age 20–44 years also incurred increased risk. In addition, hospitalizations and associated charges related to cysticercosis far exceeded those for malaria and were greater than for those for all other neglected tropical diseases combined. Neurocysticercosis is an increasing public health concern in the United States, especially among Hispanics, and costs the US health care system a substantial amount of money.",
author = "Seth O'Neal and Flecker, {Robert H.}",
year = "2015",
doi = "10.3201/eid2106.141324",
language = "English (US)",
volume = "21",
pages = "969--976",
journal = "Emerging Infectious Diseases",
issn = "1080-6040",
publisher = "Centers for Disease Control and Prevention (CDC)",
number = "6",

}

TY - JOUR

T1 - Hospitalization frequency and charges for neurocysticercosis, United States, 2003–2012

AU - O'Neal, Seth

AU - Flecker, Robert H.

PY - 2015

Y1 - 2015

N2 - Neurocysticercosis, brain infection with Taenia solium larval cysts, causes substantial neurologic illness around the world. To assess the effect of neurocysticercosis in the United States, we reviewed hospitalization discharge data in the Nationwide Inpatient Sample for 2003–2012 and found an estimated 18,584 hospitalizations for neurocysticercosis and associated hospital charges totaling >US $908 million. The risk for hospitalization was highest among Hispanics (2.5/100,000 population), a rate 35 times higher than that for the non-Hispanic white population. Nearly three-quarters of all hospitalized patients with neurocysticercosis were Hispanic. Male sex and age 20–44 years also incurred increased risk. In addition, hospitalizations and associated charges related to cysticercosis far exceeded those for malaria and were greater than for those for all other neglected tropical diseases combined. Neurocysticercosis is an increasing public health concern in the United States, especially among Hispanics, and costs the US health care system a substantial amount of money.

AB - Neurocysticercosis, brain infection with Taenia solium larval cysts, causes substantial neurologic illness around the world. To assess the effect of neurocysticercosis in the United States, we reviewed hospitalization discharge data in the Nationwide Inpatient Sample for 2003–2012 and found an estimated 18,584 hospitalizations for neurocysticercosis and associated hospital charges totaling >US $908 million. The risk for hospitalization was highest among Hispanics (2.5/100,000 population), a rate 35 times higher than that for the non-Hispanic white population. Nearly three-quarters of all hospitalized patients with neurocysticercosis were Hispanic. Male sex and age 20–44 years also incurred increased risk. In addition, hospitalizations and associated charges related to cysticercosis far exceeded those for malaria and were greater than for those for all other neglected tropical diseases combined. Neurocysticercosis is an increasing public health concern in the United States, especially among Hispanics, and costs the US health care system a substantial amount of money.

UR - http://www.scopus.com/inward/record.url?scp=84929417246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929417246&partnerID=8YFLogxK

U2 - 10.3201/eid2106.141324

DO - 10.3201/eid2106.141324

M3 - Article

VL - 21

SP - 969

EP - 976

JO - Emerging Infectious Diseases

JF - Emerging Infectious Diseases

SN - 1080-6040

IS - 6

ER -